Monitor Relapse Risk Without Provoking Recurrence

To monitor relapse risk without provoking recurrence, use Hana's routine transitions, naturally occurring delays, planned treatment changes, staff simulations without client exposure, integrity checks, and early-warning measures when they answer the decision. Avoid manufactured deprivation, dangerous context changes, communication removal, or intentional treatment failure. Define qualified authority, access, assent, withdrawal, safety, rollback, emergency response, and stopping rules before monitoring begins.

Use routine evidence first

Identify natural handoffs, planned schedule changes, ordinary delays, and existing records that answer Hana's question. Prefer preparation and observation over provocation.

Simulate systems without exposing Hana

Teams can rehearse contact trees, materials, partner roles, availability signals, and rollback decisions through tabletop scenarios. Simulation measures readiness rather than Hana's behavior.

Create hard readiness gates

Require current treatment, qualified partners, communication, health information, ordinary supports, safe setting, and escalation routes before a transition proceeds.

Define early signals and response

Record accessible help, confusion, repeated checking, withdrawal, partner delay, missing materials, and other person-specific signals with a prewritten repair or clinical-review path.

Use this sequence to monitor relapse risk safely

Begin with Hana's priority, use natural events, test systems off-line, enforce readiness, preserve access, record early signals, repair gaps, and limit conclusions to observed transitions.

Build Hana's safe relapse-monitoring plan

Create one versioned safe relapse-monitoring plan for the public-library volunteer routine. Include Hana's priority, response classes, phases, contexts, treatment versions, reinforcement, exposure, integrity, access, health, recurrence timing, safety action, direct experience, invalidity, missingness, withdrawal, candidate process, alternative explanations, design limits, decision, qualified owner, correction, and reassessment trigger. Store only decision-relevant information with role-limited access.

Validate Hana's recurrence evidence

Reproduce Hana's 12 planned handoffs, ten ready, two unready, 10/10 alternative access, 8/10 use, and 1/10 prior-target response. Verify readiness definitions, partners, schedule, AAC, treatment version, integrity, context, health, direct report, rollback, stop, safety, emergency, and missingness. Confirm that no failed support is arranged for assessment.

Connect Hana's evidence to a decision

Hana's plan uses readiness as a gate rather than an experimental variable. A failed gate triggers repair or an accessible alternative. Qualified clinicians review naturally occurring outcome data at a scheduled point, and the monitoring plan closes when it no longer changes preparation, support, or response decisions. Hana can end monitoring at any time.

Work through Hana's example

Hana has 12 routine staff handoffs during the month. The full support package is ready for ten; one lacks the visual schedule and one lacks a trained receiving partner. Among the ten ready handoffs, the alternative request is available in 10/10 and used in 8/10. The prior target response occurs in 1/10. The two unready events remain system-readiness failures and receive immediate repair. Preserve every planned and valid unit, response code, phase and context version, treatment component, reinforcement event, exposure, integrity result, access and health state, safety response, withdrawal, direct report, system failure, repair, correction, and unresolved item. This fictional example demonstrates one assessment control. It offers no diagnosis, person trait, universal relapse estimate, treatment effect, legal conclusion, coverage decision, payment promise, or outcome guarantee for Hana.

Address Hana's main interpretation risk

Allowing the two unready handoffs to proceed for data would manufacture treatment failure. Removing Hana's communication tool to test persistence would create an access violation. A low recurrence count in ten events also cannot promise future prevention. Review response and phase definitions, treatment history, reinforcement, exposure, context, integrity, access, health, partner behavior, direct experience, alternative explanations, authority, and design strength separately. A convincing graph cannot repair an unsafe, inaccessible, unwanted, or historically unsupported recurrence assessment.

Keep treatment scope and authority clear for Hana

For Hana's safe relapse-monitoring plan, the CASP public summary supplies high-level ABA behavioral-health-treatment scope for autistic people, with licensed detail outside this page. The current BACB Ethics Code addresses competence, client involvement, consent and assent when applicable, medical needs, risk, data, documentation, evaluation, discontinuation, and transition for covered people. The BACB outline supplies examination content. These sources create no individualized relapse protocol or practice authority for Hana.

Distinguish early increase from recurrence for Hana

The historical Lerman and Iwata analysis reviewed extinction data and found early increases under a defined burst criterion in a minority of reviewed data sets. An extinction burst describes a time-linked early increase after extinction begins, whereas Hana's later recurrence question requires its own phase history. The study offers no universal prevalence estimate for current care, no safety authorization, and no prediction for the public-library volunteer routine.

Use alternative-reinforcement and communication literature within scope for Hana

Athens and Vollmer evaluated differential reinforcement without extinction with seven children and varied dimensions such as immediacy, duration, and quality. The Tiger, Hanley, and Bruzek review discusses FCT assessment, response selection, partner response, schedule thinning, and related risks. These sources support careful history and delivery measurement for Hana; they supply no universal schedule, delay, consequence, or relapse outcome.

Use renewal evidence cautiously for Hana

The Podlesnik renewal review synthesizes basic and translational work on recurrence with context change while extinction or treatment contingencies remain. Much of that evidence comes from controlled laboratory arrangements. Understanding and Reacting to Relapse discusses practice-facing context and recurrence considerations. For Hana, define people, places, cues, treatment continuity, access, and integrity before applying renewal language.

Preserve broad relapse limits and communication access for Hana

Relapse and Its Mitigation distinguishes several recurrence histories and discusses mitigation concepts. It organizes hypotheses rather than proving which process occurred for Hana. ASHA's AAC portal says AAC users should always have access to communication tools or devices. Follow governing sources and preserve Hana's communication, health care, food, water, bathroom use, mobility, rest, relationships, safety, and emergency help throughout review.

Choose Hana's next bounded action

Hana chooses a receiving-partner introduction before each handoff and asks that the backup schedule stay in the same bag as her materials. Record the qualified owner, source evidence, effective date, current phase and treatment version, ordinary supports, access and health state, implementation check, accessible explanation, disagreement route, and reassessment trigger. Preserve the earlier record when responses, people, settings, systems, schedules, health, or priorities change. A repaired arrangement creates a dated phase rather than an error in Hana's prior performance.

Close Hana's relapse review

Review the safe relapse-monitoring plan with Hana, the qualified behavior analyst, relevant partners, access owners, and specialists named in the manifest. Confirm that observed recurrence remains separate from resurgence, renewal, an extinction burst, treatment drift, access failure, health change, and treatment effect; every denominator is reproducible; AAC and basic access remain protected; urgent needs received action; and conclusions stay bounded to the supported history. Keep this page draft and noindex until every required review is complete.

How to Monitor Relapse Risk Without Provoking Recurrence